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Abstract
Drosophila C virus (DCV) is a natural pathogen of Drosophila and a useful model for studying antiviral defences. The
Drosophila host is also commonly infected with the widespread endosymbiotic bacteria Wolbachia pipientis. When DCV
coinfects Wolbachia-infected D. melanogaster, virus particles accumulate more slowly and virus induced mortality is
substantially delayed. Considering that Wolbachia is estimated to infect up to two-thirds of all insect species, the observed
protective effects of Wolbachia may extend to a range of both beneficial and pest insects, including insects that vector
important viral diseases of humans, animals and plants. Currently, Wolbachia-mediated antiviral protection has only been
described from a limited number of very closely related strains that infect D. melanogaster. We used D. simulans and its
naturally occurring Wolbachia infections to test the generality of the Wolbachia-mediated antiviral protection. We generated
paired D. simulans lines either uninfected or infected with five different Wolbachia strains. Each paired fly line was
challenged with DCV and Flock House virus. Significant antiviral protection was seen for some but not all of the Wolbachia
strain-fly line combinations tested. In some cases, protection from virus-induced mortality was associated with a delay in
virus accumulation, but some Wolbachia-infected flies were tolerant to high titres of DCV. The Wolbachia strains that did
protect occurred at comparatively high density within the flies and were most closely related to the D. melanogaster
Wolbachia strain wMel. These results indicate that Wolbachia-mediated antiviral protection is not ubiquitous, a finding that
is important for understanding the distribution of Wolbachia and virus in natural insect populations.
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Introduction
As obligate intracellular parasites, viruses have intricate
associations with their hosts. Many viruses have deleterious effects
on their host including virus induced pathology, morbidity and
mortality. For this reason a suite of antiviral defence responses
have evolved. Some of these responses are conserved across
different kingdoms, while others are unique to closely related
groups of organisms. For example, viruses that infect insects
encounter some host defences that are distinctive to invertebrates,
such as the peritrophic matrix.
There are a number of motivations for studying antiviral
responses in insects. Insects are a useful model for research on
innate immune responses, and because of the evolutionary
conservation in many of these pathways, this research may lead to
an increased understanding of antiviral immunity in mammals
(reviewed in [1]). It is also important to understand insect antiviral
responses for other reasons. Viruses cause diseases in both pest
insect species and beneficial insects. Also insects are involved in the
transmission of many viruses that cause serious disease in humans,
otheranimalsand plants.Thustherearediverse reasonsforwanting
to control virus infection in insects and understanding antiviral
responses in insects may facilitate strategies to achieve this.
The vinegar fly, Drosophila melanogaster, is an appropriate model
for the study of antiviral responses. The Drosophila cellular antiviral
responses include both the intrinsic RNAi pathway and inducible
immune pathways [2–6]. In addition to host antiviral defences, D.
melanogaster are also protected from RNA viruses when infected by
the intracellular bacterium, Wolbachia pipientis [7,8]. In D.
melanogaster the interaction between Wolbachia and virus has
important implications for the outcome of viral infection.
Recent studies on antiviral responses in Drosophila have utilised
the most pathogenic of the Drosophila viruses, Drosophila C virus
(DCV). A member of the Dicistroviridae family, DCV is a natural
pathogen of D. melanogaster found in both wild and laboratory fly
populations [9,10]. Following injection of DCV into the hemocoel
of adult D. melanogaster, flies typically die within 4–6 days [11]. In
contrast, following injection of DCV into Wolbachia infected flies,
the accumulation of infectious DCV particles is delayed and flies
live for 12–14 days [7,8]. Wolbachia-mediated antiviral protection
is not limited to DCV. Wolbachia infection also protects flies from
mortality induced by a second member of the Dicistroviridae family
Cricket paralysis virus (CrPV) and a member of the Nodaviridae family
Flock House virus (FHV) [7,8]. In addition, antiviral protection has
been demonstrated in a number of D. melanogaster genetic
backgrounds and using closely related Wolbachia strains that
naturally occur in D. melanogaster, namely wMelCS and wMelPop
[7,8].
Wolbachia are predicted to infect from 20–70% of insect species
[12–14], which raises the possibility that Wolbachia may potentially
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Bacteria of the genus Wolbachia are maternally inherited
intracellular symbionts, which are best known for their propensity
to manipulate host reproductive systems [15]. Wolbachia infect a
wide range of arthropods and filarial nematodes and are classified
into 7–8 phylogenetic supergroups based on analysis of the
sequence of a number of Wolbachia genes (see [16] and references
therein). The majority of known Wolbachia strains that infect insect
species belong to either supergroup A or B [17,18]. The Wolbachia
that occur in D. melanogaster are very closely related strains from the
Mel clade of supergroup A [19].
It is currently not known whether antiviral protection is
mediated by diverse strains of Wolbachia. The fly species, D.
simulans is infected by up to six strains of Wolbachia that span across
both supergroup A and B [18,20], including three supergroup A
strains wAu, wRi and wHa and one supergroup B strain wNo
[18,20]. Here we tested whether Wolbachia-mediated protection
extends to insects other than D. melanogaster and whether each of
the Wolbachia strains could protect D. simulans from virus infection.
Our results show that some, but not all, of the Wolbachia strains
protected naturally infected D. simulans lines from virus-induced
mortality.
Results
Wolbachia strain wMel can protect D. simulans from DCV
Wolbachia strains closely related to wMel have previously been
shown to protect their natural host D. melanogaster from
accumulation of DCV particles and DCV-induced mortality
[7,8]. To establish whether wMel can protect D. simulans from
DCV, we assayed Me29, a D. simulans line that was transinfected
with wMel [21] (Table 1). Me29 flies infected with wMel and the
genetically paired population that had been cured of Wolbachia
infection were challenged with DCV and mortality was recorded
for 15 days (Figure 1A). For flies both with and without Wolbachia
the mortality in PBS injected controls was negligible. All DCV
injected wMel-free flies died by 8 days post infection (dpi), with a
median survival time of 6 days. In contrast, at 15 dpi about 50% of
wMel infected flies remained alive. These results indicate that the
presence of wMel mediates a significant decrease in DCV induced
mortality in Me29 flies.
The accumulation of infectious DCV particles was assayed in
Me29 flies with and without wMel. The titre of infectious virus in
homogenates from flies collected 2 dpi was significantly different in
flies with and without wMel (p,0.002; Figure 1B). The titre of
virus in flies without Wolbachia was estimated to be about 2600-fold
greater than in Me29 flies infected with wMel. By 10 dpi there
Figure 1. Wolbachia strain wMel provides antiviral protection in
D. simulans. (A) Graph shows survival of flies infected with DCV (black
line) or mock infected (grey line). wMel-infected (circle and plus sign) or
uninfected (triangle and cross) flies. The survival of DCV infected flies
with and without Wolbachia is significantly different (p,0.0001). Error
bars represent SEM calculated from three replicate vials. This is a
representative experiment which was repeated twice more with similar
results. (B) Graph showing accumulation of infectious DCV in wMel
infected (grey bars) or uninfected (white bar) flies. Bars represent means
from two replicates with SEM shown, and * indicates a significant
difference between the means of day 2 samples (p,0.05, unpaired t
test).
doi:10.1371/journal.ppat.1000656.g001
Table 1. Fly lines and Wolbachia strains.
Drosophila simulans line Wolbachia strain Reference
Me29 wMel Poinsot et al., 1998 [21]
CO wAu Hoffmann et al., 1996 [54]
DSR wRi Hoffmann et al., 1986 [45]
DSH wHa O’Neill & Karr, 1990 [47]
N7NO wNo Mercot & Poinsot, 1998 [46]
doi:10.1371/journal.ppat.1000656.t001
Author Summary
Many human, animal and plant viruses are transmitted
between hosts by insect vectors. Understanding the
processes that control virus infection in insects may
facilitate strategies that aim to control the spread of
important viral pathogens. Infection of the model insect
Drosophila with the endosymbiotic bacteria Wolbachia can
significantly affect the outcome of infection with patho-
genic viruses. Wolbachia is widespread in insects, so here
we tested the generality of antiviral protection across
diverse strains of the bacteria. We show that some, but not
all, strains of Wolbachia protect flies from pathogenic
viruses. These results have implications for proposed
strategies utilising Wolbachia to control the spread of
insect-transmitted viral diseases, such as dengue.
Wolbachia-Mediated Antiviral Protection
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surviving wMel infected flies had increased to a level similar
to that of Wolbachia-free flies at 2 dpi. This indicates that the
presence of wMel in Me29 flies delays rather than prevents DCV
accumulation.
D. simulans Wolbachia strains and protection from DCV
induced mortality
D. simulans populations are naturally infected with a range of
Wolbachia strains. To analyse whether diverse strains could protect
from DCV induced mortality we assayed four D. simulans lines CO,
DSR, DSH and N7NO, which are naturally infected with wAu,
wRi, wHa and wNo, respectively (Table 1). Each of the four fly
lines was treated with tetracycline to produce a genetically paired
line without Wolbachia infection. Flies with and without Wolbachia
were challenged by injection with DCV or mock infected with PBS
(Figure 2). In all cases less than 10% mortality occurred in the
mock-infected flies, indicating that in the absence of virus fly
survival was stable over the course of the experiments. The CO
flies without Wolbachia had a median survival time of 8 days
following DCV injection (Figure 2A). Strikingly, the wAu-infected
CO flies survived DCV infection; more than 90% were alive when
the experiment was terminated at 30 dpi. The wRi-infected DSR
flies had significantly better survival (p,0.0001) than Wolbachia-
free DSR flies (Figure 2B). The median survival times following
DCV infection were 14 dpi as compared to 6 dpi for flies with and
without wRi, respectively. Thus presence of either wAu or wRi in
D. simulans can mitigate DCV-induced mortality.
Not all Wolbachia strains protected flies from DCV induced
mortality. The median survival time of DSH and N7NO flies
challenged with DCV was 4 days regardless of Wolbachia infection
status for fly lines infected by wHa or wNo, respectively (Figure 2C
Figure 2. Antiviral protection of different Wolbachia strains in D. simulans. Graphs show survival of flies infected by wAu (A), wRi (B), wHa (C),
and wNo (D) challenged with DCV (black line) or mock infected (grey line). Flies with Wolbachia (circle and plus sign) and without Wolbachia (triangle
and cross). Error bars represent SEM calculated from three replicates. The survival of DCV infected flies with and without Wolbachia is significantly
different for wAu (p,0.0001), wRi (p,0.0001), and wHa (p,0.01), using log rank test on Kaplan-Meier curves. Experiments were replicated on at least
two additional independent cohorts of flies, and the results for all respective replicates of experiments shown in panel A, B and D were similar,
however the replicates for panel C varied (see Results).
doi:10.1371/journal.ppat.1000656.g002
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(p=0.001) difference between the survival curves for the DSH flies
with and without wHa infection for the representative experiment
shown in Figure 2C, a significant difference was evident in only 2
out of 4 experiments replicated on independent cohorts of flies
(data not shown). Taken together, the minor difference in survival
and non-reproducible nature of the result suggests that it is
unlikely that this difference is biologically relevant, and as such we
interpret the results as indicating that there is no protection against
DCV induced mortality in the DSH flies infected with wHa. There
was no difference between the survival curves of N7NO flies with
and without wNo infection (p=0.7). To investigate whether
protection would be evident for these lines challenged with
reduced amounts of virus we decreased the concentration of DCV
injected by 10- or 100-fold. Even at these lower doses of virus no
Wolbachia-mediated antiviral protection was observed in DSH and
N7NO flies (data not shown).
Accumulation of DCV in flies with and without Wolbachia
DCV accumulation was assayed in each D. simulans line in the
presence or absence of Wolbachia (Figure 3). DCV infected flies
were assayed at 2 dpi and the DCV titre was compared for each fly
line with and without Wolbachia infection. The average DCV titre
was approximately 800-fold lower in CO flies infected with wAu
compared to paired Wolbachia-free flies, and an unpaired t test
showed this to be a significant difference (p,0.05; Figure 3A).
Interestingly, although wAu infected flies survived DCV infection
(Figure 2A), virus continued to accumulate beyond 2 dpi and high
titres of DCV were observed in wAu-infected flies harvested at
both 10 and 30 dpi (Figure 3A). This shows that these flies did not
clear the virus infection. The titre of DCV was similar when
comparing flies with and without Wolbachia at 2 dpi for each of the
three other fly lines assayed (Figure 3B–D).
D. simulans Wolbachia strains and protection from FHV
induced mortality
Having identified that some but not all Wolbachia strains mediate
protection against DCV in the D. simulans lines tested, we next
investigated whether antiviral protection was consistent across
different viruses. Flies with and without Wolbachia were challenged
by injection with FHV or mock infected with PBS (Figure 4). In all
cases mortality in the mock-infected control flies was negligible.
The CO flies without Wolbachia infection reached 100% mortality
within 7 days of injection with FHV (Figure 4A). Similar to
challenge with DCV the wAu-infected flies survived FHV
infection; more than 90% were alive when the experiment was
terminated at 24 dpi. The wRi-infected DSR flies had significantly
better survival (p,0.0001) than Wolbachia-free DSR flies
Figure 3. The effect of different Wolbachia strains on the accumulation of DCV in D. simulans. Graphs show accumulation of infectious DCV
in flies with (grey bar) or without (white bar) wAu (A), wRi (B), wHa (C), and wNo (D). Bars represent means from two replicates with SEM shown, and
* indicates a significant difference between the means of day 2 samples (p,0.05, unpaired t test).
doi:10.1371/journal.ppat.1000656.g003
Wolbachia-Mediated Antiviral Protection
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wRi (B),wHa (C), andwNo (D) challenged with FHV (blackline) or mock infected (grey line).Wolbachiainfected(circleandplussign)anduninfected(triangle
and cross) flies. Error bars represent SEM calculated from three replicates. The survival of FHV infected flies with and without Wolbachia is significantly
different for wAu and wRi (p,0.0001, log rank test on Kaplan-Meier curves). For each fly line a similar result was recorded in a replicate experiment.
doi:10.1371/journal.ppat.1000656.g004
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with FHV were 10 days as compared to 7 days with and without
wRi, respectively. Thus median time to death was reduced in both
DCV and FHV infections for wRi-infected DSR flies. No virus-
induced mortality was observed in wAu-infected CO flies for either
virus.
Not all of the fly lines were protected from FHV-induced
mortality by Wolbachia infection. The median survival time of
DSH flies challenged with FHV was 6 days regardless of the
presence or absence of wHa (Figure 4C) and there was no
significant difference in the survival curves (p=0.4). For the
N7NO line there was no difference between the survival curves
with and without wNo infection (p=0.5; Figure 4D).
Wolbachia density in fly lines
To investigate whether virus protection correlated with the
density of the Wolbachia in the fly lines, we utilized quantitative
PCR to determine Wolbachia density from pools of 5 male flies
from each fly line. Estimates of abundance for a single copy
Wolbachia gene were determined and then normalized against
abundance of a single copy host gene to determine relative
abundance of Wolbachia (Figure 5). The three Wolbachia strains
(wMel, wRi and wAu ) that gave strong antiviral protection in the
D. simulans lines, were significantly more abundant in these flies
than the strains that gave no protection (wHa and wNo).
Discussion
Many insect species are infected with Wolbachia, raising the
possibility that Wolbachia-mediated antiviral protection could be a
widespread phenomenon. Wolbachia strains vary both between host
species and within a host species (for example [20]). Naturally
occurring Wolbachia strains in D. melanogaster ubiquitously protect
against DCV [7,8], however these strains are very closely related
[19]. Wolbachia is maternally inherited and therefore has a close
association with its host. Using D. simulans fly lines that are
naturally infected by different Wolbachia strains we showed that
some strains did not mitigate virus-induced mortality. Strains wAu
and wRi protected the CO and DSH host flies respectively. In
contrast, neither wHa nor wNo protected their host lines from
DCV induced mortality. Phylogenetic analysis indicates that the
D. simulans Wolbachia strains wAu and wRi are most similar to
wMel. Whereas of the phylogenetic supergroup A strains, wHa is
the most divergent to wMel, and wNo belongs to supergroup B
[18,20]. This may suggest that there is a Wolbachia feature involved
in antiviral protection, which is conserved among strains more
closely related to wMel.
With the exception of the Me29 flies infected by wMel, natural
host-Wolbachia combinations were used. The D. simulans Wolbachia
strains are known to be associated with different mitochondrial
haplotypes [22] and we did not control for host nuclear genetic
background which can have an impact on virus infection [7]. As a
consequence it is not possible to rule out that intrinsic variability in
susceptibility to virus that is linked to the host background has an
influence on the outcome of Wolbachia-mediated protection in our
experiments. Indeed there is variation in the time to death of
Wolbachia-free D. simulans lines used in this study when challenged
with DCV (Figure 2), although interestingly these same Wolbachia-
free lines showed similar time to death when challenged with FHV
(Figure 4). Antiviral protection was observed in both D. melanogaster
and D. simulans when infected with wMel. This indicates that
antiviral protection mediated by Wolbachia can be transferred
between different host species.
Since protection against DCV was not seen in all the fly lines
infected with the Wolbachia strains, we tested whether there is
specificity in protection against different viruses. Infection of D.
melanogaster by Wolbachia protected the flies from all RNA viruses
tested [7,8]. Although each of these viruses was a non-enveloped,
positive sense RNA virus, the viruses come from a broad spectrum
of virus families. Compared to DCV the most divergent of these
viruses is FHV. DCV is a member of the Dicistroviridae family and
has a single genomic RNA that is not capped but is polyadenylated
[9]. The genome is a bicistronic mRNA from which the structural
and non-structural polyproteins are translated via internal
ribosome entry sites [23–25]. DCV RNA replication occurs on
membranes derived from the golgi [26]. In contrast, the nodavirus
FHV genome comprises two mRNA sense RNAs which are
capped but not polyadenylated and a third subgenomic RNA is
synthesised during replication [27]. FHV genome replication
occurs on mitochondrial membranes [28,29]. Interestingly,
although DCV and FHV have distinct infection cycles the same
Wolbachia strains protected D. simulans lines from both DCV and
FHV induced mortality. This suggests that the mechanism of
protection from virus-induced mortality may be common across
diverse viruses, although it is not currently known what the
mechanism of viral pathogenesis is in flies infected with either
DCV or FHV. It remains to be seen whether the same host-
Wolbachia combinations that do or do not protect against DCV
and FHV have similar outcomes for other viruses, or indeed other
types of pathogens.
Concurrent with protection from virus induced mortality in D.
melanogaster was a delay in accumulation of DCV [8]. Here a similar
result was seen with wMel protection in D. simulans, the amount of
infectious virus accumulated 2 dpi was significantly lower in
Wolbachia infected flies. By 10 dpi the DCV titre in Wolbachia
infected flies was similar to the day 2 titre for Wolbachia-free flies. It
would be tempting to speculate that the resistance to DCV
accumulation protects the flies from DCV induced mortality,
however, the results observed with the D. simulans Wolbachia strains
complicate this interpretation. The CO flies infected with wAu
survived DCV infection beyond 30 dpi, whereas the Wolbachia-free
flies were clearly susceptible to DCV-induced mortality. wAu
infected flies had by 10 dpi accumulated high titres of DCV and the
virus titre remained high at 30 dpi. This shows that wAu infected
flies were tolerant of DCV infection, that is the virus accumulated
Figure 5. Relative-density of Wolbachia strains in D. simulans. For
each fly line the graph shows the relative abundance of Wolbachia to
host genomic DNA estimated using quantitative PCR. Bars represent the
mean of 10 replicates and error bars are SEM.
doi:10.1371/journal.ppat.1000656.g005
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infected DSR flies were protected from DCV induced mortality, at
2 dpi there was no difference in virus accumulation in flies with and
without wRi. We cannot rule out that accumulation was delayed in
wRi-infected flies earlier than 2 dpi.
Taken together our results indicate that Wolbachia-mediated
antiviral protection could arise in flies in two ways. Wolbachia can
interfere with the virus infection cycle to delay virus accumulation,
that is, it can induce resistance to virus infection in the host. In
addition Wolbachia infection can protect flies from the pathogenesis
associated with virus infection, that is, it can increase host
tolerance to virus infection. The processes or mechanisms involved
in resistance and tolerance may be the same, independent or
overlap. Our results show that Wolbachia strains can induce both
resistance and tolerance to DCV infection, but importantly
prolonged resistance is not a requirement for protection against
DCV-induced mortality. These results are consistent with those
reported for FHV in Wolbachia infected D. melanogaster, where there
was no difference in FHV accumulation 6 dpi but Wolbachia
infection protected flies from FHV induced mortality [7].
The strains of Wolbachia that mediate antiviral protection were
anticipated to be present at higher density in infected flies [31,32].
We confirmed the density of Wolbachia in the particular fly lines
used in this study correlated with protection. The density of
Wolbachia was assayed in whole flies as previous assays have shown
that in addition to reproductive tissues somatic tissues are
commonly infected with Wolbachia [33,34]. Further experiments
controlling the density of a single strain are required to determine
if high Wolbachia density is a pre-requisite for antiviral protection.
The mechanisms or processes by which Wolbachia protects the
host from virus are not yet understood. The correlation of high
bacterial density of the strains that protect the host suggests that
Wolbachia density may be important for antiviral protection.
Potentially protection may require a threshold of Wolbachia density
to be exceeded, which would be consistent with protection being a
consequence of competition between the two intracellular microbes
for limited host resources. Antiviral protection may also be
dependent on the distribution of Wolbachia between tissue or cell
types. Wolbachia have been identified in a range of somatic and
reproductive tissues in insects and are known to display variable
tissue tropism depending on infecting strain and host combination
[33–35]. Late in infection DCV is widely distributed in Drosophila
tissues including both reproductive and somatic tissues [36–38],
givingabundantopportunityforoverlap with Wolbachiadistribution.
However, little is known about the spread of virus from the initial
infection site or if replication of the virus is equivalent in all of the
susceptible tissues. It is possible that there are tissues or cell types
that are critical to virus replication or pathogenesis and that
Wolbachia-mediated protection occurs by exclusion or regulation of
virus in these tissues. In addition, if particular tissues are critical for
pathogenesis,tolerancemaybe a resultofprotectionof thosetissues.
The relatively close phylogenetic relationships of the strains that
do confer antiviral protection compared to non-protective strains,
suggests that other features of the Wolbachia strains could
determine the outcome of virus infection. Protection via both
resistance and tolerance could be induced by modulation of host
antiviral responses by Wolbachia. For example, proteins from the
ankyrin family, which can play a role in innate immune pathways,
vary considerably both in number and sequence between
Wolbachia strains [39–42]. Interestingly defence against bacterial
infection in flies via the melanisation response has been shown to
involve both resistance and tolerance effects [43].
Wolbachia are able to rapidly invade host populations and are
often maintained at high prevalence in these populations [44]. In
many cases this is achieved at least in part by Wolbachia
manipulation of host reproductive systems to increase the
prevalence of infected individuals in the host population. For
example the Wolbachia strains wRi, wHa and wNo used in this
study induce cytoplasmic incompatibility in D. simulans, however
wAu does not manipulate host reproductive systems [45–48]. In
the absence of strong reproductive parasitism, theory predicts that
to be maintained in a host population Wolbachia must provide a
fitness advantage to the female host (reviewed in [49,50]).
Wolbachia-mediated protection from viruses and other pathogens
[51] may confer this fitness advantage. It is therefore likely that the
interactions between Wolbachia and viruses such as DCV impact
on the distribution of both microbes in insect populations.
Materials and Methods
Viruses
Plaque purified DCV isolate EB [11] and FHV [52] were
propagated and purified from DL2 cells [53]. DL2 cells were
maintained in Schneider’s media supplemented with 10% FBS, 1
x glutamine and 1 x penstrep (Invitrogen) at 27.5uC. Cells grown
in 75 cm
2 flasks were infected with either DCV or FHV at a low
multiplicity of infection (,1) and harvested at 4–5 dpi. Cells were
lysed by two rounds of freeze-thawing and cell debris removed by
centrifugation at 5,000 rpm for 5 min. The virus was purified
from the supernatant by pelleting through a 6 ml 10% sucrose
cushion at 27,000 rpm at 12uC for 3 hours in a SW28 swing
bucket rotor (Beckman). The resuspended virus was layered onto a
continuous 10–40% w/v sucrose gradient and centrifuged at
27,000 rpm at 12uC for 3 hours in a SW41 swing bucket rotor
(Beckman). The virus-containing fractions were harvested, diluted
in 50 mM Tris pH 7.4 and virus was pelleted by centrifuga-
tion at 27,000 rpm, 12uC for 3 hours. The virus was resuspended
in 50 mM Tris pH 7.4 at 4uC overnight, aliquoted and
stored at 220uC. The concentration of tissue culture infectious
units (IU) of each virus preparation was determined by replicate
TCID50 analysis on two separate frozen aliquots, as previously
described [8].
Flies and Wolbachia
All Wolbachia infected fly lines were obtained from the culture
collection in the O’Neill lab and were maintained on standard
cornmeal diet at a constant temperature of 25uC with a 12-hour
light/dark cycle. The D. simulans fly line Me29 is infected with
wMel. The wMel infection was established by injection of
Wolbachia containing cytoplasm from D. melanogaster Wien 5
embryos into D. simulans NHaTC embryos [21]. The other D.
simulans lines are naturally infected with Wolbachia strains as
previously described and are listed in Table 1 [45–47,54].
Preparation of Wolbachia- and virus-free fly lines
Virus-free populations of each of the Wolbachia containing fly
line were prepared essentially as previously described [55]. Briefly,
flies were aged for at least 20 days, transferred to fresh media
(supplemented with dry yeast) and allowed to lay eggs for up to
16 hours. The eggs were collected from the surface of the media
and treated for 4 minutes in 1.7% (w/v) sodium hypochlorite
solution to remove the chorion. After treatment the eggs were
thoroughly rinsed with water, transferred to moist filter paper and
placed on fresh virus-free media. Virus-free flies were maintained
separately from untreated stocks.
To generate fly lines free of Wolbachia each virus-free Wolbachia
infected fly line was treated with 0.03% tetracycline [45].
Wolbachia-Mediated Antiviral Protection
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four generations to recover before being used for experiments.
Survival bioassays
Drosophila were infected with DCV, FHV or mock infected by
microinjection of virus or PBS into the upper lateral part of the
abdomen. Samples were injected using needles pulled from
borosilicate glass capillaries and a pulse pressure micro-injector
into 4–7 day old male flies that were anaesthetised with carbon
dioxide. For each fly line assayed, three groups of 15 flies were
injected with virus and one group of 15 flies were injected with
PBS. After injection flies were maintained in vials at a constant
temperature of 25uC with a 12 h light/dark cycle and mortality
was recorded daily. Mortality that occurred within one day of
injection was deemed to be due to injury. Each experiment was
replicated using independent cohorts of flies. Survival curves were
compared using Kaplan-Meier analysis and log-rank statistics
reported (GraphPad Prism). For each assay described in this paper
a fresh aliquot of either DCV or FHV was defrosted and diluted to
1610
8 IU/ml before use.
Virus accumulation assays
The accumulation of infectious DCV particles in both Wolbachia
infected and uninfected flies was measured. For each of the five fly
lines, groups of flies with and without Wolbachia were injected with
DCV as for survival bioassays. At designated times post injection,
twopoolsoffourliveDCVinjectedflieswerecollectedandfrozenat
220uC. Flies from all Wolbachia infected and uninfected fly lines
were collected at 2 dpi. For Me29, DSR and CO flies infected with
Wolbachia samples were also collected at 10 days post injection; for
N7NO and DSH containing Wolbachia and all tet-treated lines there
were not enough live flies remaining at 10 days for collection. For
CO-Wolbachia flies an additional collection was included at 30 dpi.
Each pool of four flies was homogenised in 100 ml of PBS with
two 3 mm beads (Sigma-Aldrich) using a Mini BeadBeater-96
(Biospec Products) for 60 seconds. The homogenates were clarified
by centrifuging at 14 K for 8 minutes. The virus–containing
supernatant was aliquoted and stored at 220uC. Virus titre was
determined usingtheTCID50assayaspreviouslydescribed[8].The
two replicates for each fly population were assayed on different days
to control for between-day variation in TCID50 assays. Statistical
analysis of the data was done using unpaired t tests to compare the
geometric means of the duplicate samples between flies of each line
with and without Wolbachia at 2 dpi (GraphPad Prism).
Analysis of Wolbachia density
For each fly line 200 eggs were collected and incubated on fresh
food with a constant temperature of 25uC for 10 days. Freshly
emerged flies were collected for 8 hours, aged to 4 days old and then
fivemaleflies from a singlecollection werepooled.For eachfly line a
total of 10 pools of flies were collected from independent bottles and
the DNA extracted using a DNeasy Blood and Tissue Kit as per
manufacturers instructions (Qiagen). The relative ratio of Wolbachia
to fly genomic DNA was determined by quantitative PCR. Each
10 mlqPCRreaction included5 mL ofSybrGreenqPCR Supermix-
UDG (Invitrogen), 1 mL of DNA template and 1 mMe a c ho ft h e
forward and reverse primers. Primers for Wolbachia were designed
from an alignment of the sequence of the WSP genes from all five
Wolbachia strains (wspFQALL 59 GCATTTGGTTAYAAAATG-
GACGA 39 and wspRQALL 59 GGAGTGATAGGCATATCTT-
CAAT 39) and for the host gene RPS17 (Dmel.rps17F 59CACTCC-
CAGGTGCGTGGTAT 39 and Dmel.rps17R 59GGAGACGGC-
CGGGACGTAGT 39). Reactions were done in duplicate in a
Rotor-gene thermal cycler (Corbett Life Sciences) with the following
conditions: one cycle of 50uC2m i n ,9 5 uC 2 min, followed by 40
cycles of 95uC 5 sec, 60uC 5 sec, 72uC 10 sec. A third technical
replicate was done where necessary and DNA extracted from flies
without Wolbachia was used as a negative control. Ratios were
calculated in Qgene and statistical analysis included Mann-Whitney
t test to compare differences of the means.
Accession numbers
EF423761 wsp wRi; DQ235409 wsp wAu; AF020074 wsp wNo;
AF020073 wsp wHa; NM_079278 RPS17.
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